What does CUSIP 35655L107 represent in this 13F holders report?

CUSIP 35655L107 is the security identifier for FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS used to aggregate holder disclosures.

How many institutions held FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in Q1 2024?

No institutional holders were reported for FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in Q1 2024; review adjacent reporting periods for trend context.

FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

CUSIP: 35655L107

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class: Equity / SPONSORED ADS
Total 13F shares: 0
Share change: -1,466,507
Total reported value: $0
Number of holders: 0
Value change: -$9,326,984
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 35655L107?
CUSIP 35655L107 identifies FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2023

Recent filing periods for CUSIP 35655L107:

Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022

FREELINE THERAPEUTICS HLDGS - SPONSORED ADS (FRLN)

Q1 2024 13F Holders as of 31 Mar 2024

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of FRLN - FREELINE THERAPEUTICS HLDGS - SPONSORED ADS as of Q1 2024.